Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

Before Recommending the RTS,S Malaria Vaccine for Wider Use, WHO Should Address Three Key Considerations

Last month, the world woke up to promising news on malaria prevention: administering an existing malaria vaccine (RTS,S) in addition to antimalarial drugs before the rainy season reduced child hospitalizations and deaths by approximately 70 percent in Burkina Faso and Mali. These results arrived ahead of a forthcoming decision from the World Health Organization on whether to recommend RTS,S for broader use. This blog argues that WHO should consider value for money and address three key considerations before making their reccomendation.

Figure 1. Comparison of per patient consumption of oxygen for oxygen therapy versus ventilators

More than Oxygen Supply: How to Make the Current Global Fund COVID-19 Response Mechanism a Success for Patients

The global COVID-19 pandemic has highlighted the pressing need to improve oxygen supplies around the world. In this blog, we highlight key objectives that countries need to consider in their funding applications for support from the CRM for the successful scale up of oxygen and critical care.

An image of a group of women in India wearing masks.

India Needs to Focus on Three Urgent Actions to Mitigate its COVID-19 Humanitarian Crisis

India’s second COVID-19 wave has been explosive, reaching world record totals of over 300,000 daily officially reported cases. The true number is likely to be much higher, with a large number of cases missed as indicated by the delays in testing and rapidly rising positivity rates - currently one in every four people tested are positive for COVID-19 across India. Leading models estimate that there could be over 1 million cases per day. The health service has collapsed, with queues of ambulances parked outside full hospitals, oxygen and drug shortages in multiple states, and life-saving non-COVID services interrupted.

An image of a doctor working on a laptop.

Rapid Priority Setting in Low- and Middle-Income Countries: The Potential of Adaptive Health Technology Assessments

Health budgets are limited and decision makers in all countries face very challenging decisions about which health interventions will be provided, and which will not. COVID has only added to this pressing priority setting problem. In this blog, we highlight key takeaways from our recent commentary in the BMJ Global Health, where we make the case for “adaptive health technology assessment,” or “aHTA.”

A figure of the summary of costs and consequences to consider in COVID-19 vaccine HTA.

Who Gets a COVID-19 Vaccine and Who Pays? The Need for Economic Analysis

In 2020, epidemiological modelling went from relative obscurity to being central in helping governments, and the public, understand COVID-19 as it spread around the world. In 2021, with the emergence of effective COVID-19 vaccines, Health Technology Assessment (HTA) will be critical to making the best possible decisions in bringing the pandemic under control, particularly in low-and middle-income countries (LMICs). In this blog we look at the potential of HTA to inform how much vaccine countries should buy, who should pay, and how vaccines can be most effectively delivered.

A close up of an oxygen tank and note paper with data filled in

We Can Stop Preventable COVID Deaths by Urgently Prioritising Medical Oxygen and Essential Critical Care

The COVID-19 pandemic is a critical illness crisis, with more than two million deaths worldwide and hospitals overburdened with 67 percent of COVID-19 admissions requiring oxygen. With the emergence of new variants and the rise of second or third epidemic waves, there is unprecedented demand for oxygen as a life-sustaining, first-line therapeutic and an essential resource when caring for the critically ill.